Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Recombinant Human Growth Hormone

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ferring's Zomacton (Somatropin) Receives Suppl Approvals in the U.S
    Ferring's Zomacton (Somatropin) Receives Suppl Approvals in the U.S

    02 Apr 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019774

    FDA
    02 Apr 2024
    Share Share
    Genexine's weekly growth hormone equal to Novo shot in phase 3
    Genexine's weekly growth hormone equal to Novo shot in phase 3

    31 Aug 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/genexines-weekly-growth-hormone-equal-novo-shot-phase-3-teeing-filing-china

    Nick Paul Taylor FIERCE BIOTECH
    31 Aug 2023
    Share Share
    Growth hormone from Novo Nordisk is in shortage over manufacturing delays
    Growth hormone from Novo Nordisk is in shortage over manufacturing delays

    21 Mar 2023

    // Beth Snyder Bulik ENDPTS

    https://endpts.com/novo-nordisk-remains-under-uk-scrutiny-as-mhra-conducts-its-own-review-in-incredibly-rare-case/

    Beth Snyder Bulik ENDPTS
    21 Mar 2023
    Share Share
    Sandoz's Biologic Omnitrope (Somatropin) Receives Approval in the U.S.
    Sandoz's Biologic Omnitrope (Somatropin) Receives Approval in the U.S.

    25 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021426

    FDA
    25 Jan 2022
    Share Share
    Pfizer stumbles close to finish line in growth hormone race
    Pfizer stumbles close to finish line in growth hormone race

    27 Sep 2021

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/pfizer-stumbles-close-to-finish-line-growth-hormone-race-extending-lead-rival-ascendis

    Nick Paul Taylor FIERCEBIOTECH
    27 Sep 2021
    Share Share
    Pfizer gets some encouraging PhIII news on a franchise savior, $295M upfront?
    Pfizer gets some encouraging PhIII news on a franchise savior, $295M upfront?

    22 Oct 2019

    // John Carroll ENDPTS

    https://endpts.com/pfizer-gets-some-encouraging-phiii-news-on-a-franchise-savior-but-is-a-dosing-advantage-worth-the-295m-upfront/

    John Carroll ENDPTS
    22 Oct 2019
    Share Share